Table III.
Growth rate (mm/year) | |||||
---|---|---|---|---|---|
Ref | n | Initial AAA diameter | Statin users | Non statin users | Risk factors adjusted for in analyses |
[13] | 130 | 45 | −0.5 | 4 | No adjustment |
[14] | 150 | 38 | AED −1.16 (95% CI, −1.99, −0.33) | Age, gender, initial AAA diameter, intermittent claudication, DM, COPD, NSAID prescription | |
[15] | 121 | 39 | 1.9±1.8* | 2.6±2.4* | No adjustment |
[16] | 147 | 41 (±8.0) | AED −1.2 (95% CI, −2.3, −.06) | Age, gender, initial AAA diameter, height, weight, DM, cerebral vascular disease, hypertension, creatinine clearance, hyperlipidaemia | |
[17] | 213 | 40 (37–44) | 1.6 | 2.5 | No adjustment |
difference in AAA growth rate not statistically significant (p>0.05); AED, adjusted estimated difference for statin use; COPD, chronic obstructive pulmonary disease.